In adult ALL patients, IKAROS positively regulates the transcription of MYCBP2 but represses the transcription of the c-MYC gene, and sequence analysis of the promoter regions of both c-MYC and MYCBP2 revealed strong IKAROS-binding sites. The gene discussed is MYC; the disease is acute lymphoblastic leukemia.